Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Receivables - Other: 2018-2022

Historic Receivables - Other for Ani Pharmaceuticals (ANIP) over the last 3 years, with Dec 2022 value amounting to $5.0 million.

  • Ani Pharmaceuticals' Receivables - Other was N/A to $5.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $5.0 million, marking a year-over-year change of. This contributed to the annual value of $5.0 million for FY2022, which is N/A change from last year.
  • As of FY2022, Ani Pharmaceuticals' Receivables - Other stood at $5.0 million, which was up 4,900.00% from $100,000 recorded in FY2019.
  • Over the past 5 years, Ani Pharmaceuticals' Receivables - Other peaked at $5.0 million during FY2022, and registered a low of $100,000 during FY2018.
  • Its 1-year average for Receivables - Other is $5.0 million, with a median of $5.0 million in 2022.